NEA 18 Venture Growth Equity, L.P.'s Form 4 filing
NeueHealth, Inc. (NEUE) · filed Apr 10, 2024
- Accession no.
- 0000950170-24-043472
- Filed
- Apr 10, 2024, 6:51 PM ET
- Trade date
- Apr 8, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 derivative transaction. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| NEA 18 Venture Growth Equity, L.P.CIK 0001880239 | 10% Owner |
| NEA Partners 18 VGE, L.P.CIK 0001898446 | 10% Owner |
| Nea 18 Vge GP, LLCCIK 0001898598 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2024 | Common Stock | PPurchaseAcquired | +371,187 | –F2 | – | 371,187 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Warrants to be issued pursuant to the Warrantholders Agreement and the Credit Agreement, dated August 4, 2023, as amended by that certain Incremental Amendment No. 1, dated as of October 2, 2023, and that certain Incremental Amendment No. 2, dated as of April 8, 2024, between the Issuer and the lenders thereto.
Referenced by the price of 1 transaction in Table II.